(Q31143771)

29 June 2017

Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. (English)

1 reference

29 June 2017

Swiss HIV Cohort Study

12

object named as

Swiss HIV Cohort Study

1 reference

29 June 2017

5

M Battegay

1 reference

29 June 2017

8

P E Tarr

1 reference

29 June 2017

A Nguyen

1

1 reference

29 June 2017

A Calmy

2

1 reference

29 June 2017

V Schiffer

3

1 reference

29 June 2017

E Bernasconi

4

1 reference

29 June 2017

M Opravil

6

1 reference

29 June 2017

J-M Evison

7

1 reference

29 June 2017

P Schmid

9

1 reference

29 June 2017

T Perneger

10

1 reference

29 June 2017

B Hirschel

11

1 reference

29 June 2017

language of work or name

1 reference

22 January 2008

1 reference

29 June 2017

1 reference

29 June 2017

9

1 reference

29 June 2017

3

1 reference

29 June 2017

142-150

1 reference

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

29 June 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Acquired and inherited lipodystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Risk factors for lipodystrophy in the CISAI cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Toxic metabolic syndrome associated with HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00537.X

10.1111/J.1468-1293.2007.00537.X

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference